Status:
RECRUITING
Metabolic FingerPrinting
Lead Sponsor:
Arcensus GmbH
Conditions:
Genetic Disease
Eligibility:
All Genders
2+ years
Brief Summary
The MetaPrint study aims to characterize the metabolic fingerprint of genetic diseases in order to enhance knowledge on the physiological disease status and establish so new tools for diagnosing, moni...
Eligibility Criteria
Inclusion
- Informed consent is obtained from the participant or from the parent/ legal guardian
- The participant is 2 months or older
- The participant is diagnosed with a genetic disease
- The participant is a first degree relative of a subject diagnosed with a genetic disease
Exclusion
- Informed consent is not obtained from the participant or from the parent/ legal guardian
- The participant is younger than 2 months
- The participant is not diagnosed with a genetic disease
- The participant is not a first degree relative of a subject diagnosed with a genetic disease
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT05305729
Start Date
March 1 2021
End Date
March 1 2026
Last Update
March 31 2022
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Center Mother Teresa
Tirana, Albania, 1000
2
The Children's hospital & Institute of child health
Lahore, Punjab Province, Pakistan, 54000
3
Pakistan Institute of Medical Sciences (PIMS)
Islamabad, Pakistan, 4485
4
Children's Hospital & The Institute of Child Health
Multan, Pakistan, 60000